Mr. Andre Larente reports

DIAGNOS ANNOUNCES THE OFFICIAL OPENING OF THE AI ASSISTED SCREENING CLINIC AT MAGRABI HOSPITAL WITH THE PRESENCE OF THE UNDERSECRETARY OF THE MINISTRY OF HEALTH OF SAUDI ARABIA

Diagnos Inc. has officially opened the initial clinics at the Magrabi Hospital in the Kingdom of Saudi Arabia.

Dr. Ibrahim Al-Omar, undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the early detection unit for diabetic retinopathy operated by Diagnos's artificial intelligence (AI) technology at Magrabi Eye, Ear and Dental Hospital in Riyadh, the first of its kind in the kingdom. The inauguration was attended by the executive management of the Magrabi Group, represented by Mutasim Alireza, managing director, Dr. Tariq Al-Hamad, regional operations director, senior retinal consultants, Yves-Stephane Couture, vice-president of Diagnos, and members of the management of Kanhoor Company and Bayer Pharmaceuticals.

When asked, Dr. Walid bin Abdul Rahman Al-Turki, head of the retinal departments at Magrabi Group in Riyadh, stated that the aim of this unit is to examine the largest possible number of diabetic patients who are at risk of developing retinal diseases associated with them, which unfortunately may end in a gradual complete loss of vision. It is known that the incidence of diabetes in the kingdom is about 27 per cent of the population, which indicates the extent of the potential risk. At the conclusion of the interview, Dr. Al-Turki stated that the initiative is in its infancy and the Magrabi Group will develop and circulate it in all branches upon completion of its review.

Magrabi Hospitals and Centers has 34 branches in the Middle East -- 22 of them are in the kingdom in Riyadh, Jeddah, Makkah, Dammam, Khobar, Al-Ahsa, Jubail, Asir, Jazan, Madinah and Qassim. Magrabi Hospitals and Centers Group was established in Jeddah in 1955 as the first hospital specialized in ophthalmology and, today, it is the largest specialized medical network in the region.

The event was reported by the SABQ on-line newspaper.

"We extend our best wishes to Magrabi hospitals. We would also like to thank everyone in attendance for their time and efforts in making this project a reality. The main beneficiaries will be many thousands of diabetic patients whose vision can now be protected through this collaboration," said Andre Larente, president of Diagnos.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire AI platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.